• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga Pro's Top 5 Stocks To Watch For Tuesday, May 24, 2022: PINS, COST, MSPR, AEMD, DTC

    5/24/22 9:08:20 AM ET
    $AEMD
    $COST
    $DTC
    $FB
    Medical/Dental Instruments
    Health Care
    Department/Specialty Retail Stores
    Consumer Discretionary
    Get the next $AEMD alert in real time by email

    Today's 5 Stock Ideas:

    • Pinterest (PINS) - Shares were down 16% in pre-market action following a Q2 warning out of peer in the social space, Snap (SNAP). The Snap guidance also brought down larger social media players like Facebook (FB) and Twitter (TWTR), which subsequently brought the entire stock market lower.

    • Costco (COST) - Will report Q3 earnings after market close on Thursday. Shares have fallen about 15% over the last week as many retailers have been reporting disappoint quarterly results.

    • MSP Recovery (MSPR) - A recent special purpose acquisition corporation (SPAC) deal with Lionheart Acquisition Corp. II (LCAP). MSP Recovery CEO, John Ruiz, will interview on Benzinga's "Benzinga Live" YouTube show Tuesday at 12:15 p.m. EDT.

    • Aethlon Medical (AEMD) - Traders have been circulating this stock as a potential play on monkeypox concerns. While shares of this penny stock have been up nearly 70% over the last couple weeks, the company does not appear to be developing a treatment specific to monkeypox. World Health Organization officials have said the risk of monkeypox to the public is low.

    • Solo Brands (DTC) - A play on summer! Solo Brands operates four premium outdoor lifestyle brands: Solo Stove, Oru, ISLE, and Chubbies apparel.

     

    Benzinga programming note: we've started a podcast for the Stocks To Watch alert! Click here to see all the episodes.

    Hosted by the Benzinga Pro newsdesk's Brent Slava and Steve Krause, the podcast will give more in-depth information on the ideas presented in the daily Stocks To Watch alert!

    Listeners can find the podcast on Spotify and Apple by searching "Benzinga Stocks To Watch."

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $COST
    $DTC
    $FB

    CompanyDatePrice TargetRatingAnalyst
    Costco Wholesale Corporation
    $COST
    3/6/2026$1100.00 → $1125.00Outperform
    Telsey Advisory Group
    Pinterest Inc.
    $PINS
    3/2/2026Buy → Hold
    Argus
    Costco Wholesale Corporation
    $COST
    2/27/2026$1185.00Buy
    BofA Securities
    Pinterest Inc.
    $PINS
    2/13/2026$16.00Buy → Hold
    Deutsche Bank
    Pinterest Inc.
    $PINS
    2/13/2026$17.00Outperform → Sector Perform
    RBC Capital Mkts
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Outperform → Neutral
    Robert W. Baird
    Pinterest Inc.
    $PINS
    2/13/2026$19.00Buy → Neutral
    Citigroup
    More analyst ratings

    $AEMD
    $COST
    $DTC
    $FB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $AEMD
    $COST
    $DTC
    $FB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Walcott Wanjiku Juanita

    4 - PINTEREST, INC. (0001506293) (Issuer)

    3/23/26 5:56:38 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 4 filed by Brown Claude Leonard

    4 - PINTEREST, INC. (0001506293) (Issuer)

    3/23/26 5:55:08 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 4 filed by Brau Donnelly Julia

    4 - PINTEREST, INC. (0001506293) (Issuer)

    3/23/26 5:52:28 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AEMD
    $COST
    $DTC
    $FB
    SEC Filings

    View All

    SEC Form 8-K filed by Aethlon Medical Inc.

    8-K - AETHLON MEDICAL INC (0000882291) (Filer)

    3/17/26 9:15:09 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Costco Wholesale Corporation

    10-Q - COSTCO WHOLESALE CORP /NEW (0000909832) (Filer)

    3/11/26 4:37:54 PM ET
    $COST
    Department/Specialty Retail Stores
    Consumer Discretionary

    Costco Wholesale Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - COSTCO WHOLESALE CORP /NEW (0000909832) (Filer)

    3/5/26 4:19:07 PM ET
    $COST
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AEMD
    $COST
    $DTC
    $FB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Costco with a new price target

    Telsey Advisory Group reiterated coverage of Costco with a rating of Outperform and set a new price target of $1,125.00 from $1,100.00 previously

    3/6/26 8:39:58 AM ET
    $COST
    Department/Specialty Retail Stores
    Consumer Discretionary

    Pinterest downgraded by Argus

    Argus downgraded Pinterest from Buy to Hold

    3/2/26 8:00:47 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    BofA Securities initiated coverage on Costco with a new price target

    BofA Securities initiated coverage of Costco with a rating of Buy and set a new price target of $1,185.00

    2/27/26 8:31:30 AM ET
    $COST
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AEMD
    $COST
    $DTC
    $FB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Metz Christopher T bought $324,804 worth of shares (250,000 units at $1.30), increasing direct ownership by 100% to 500,000 units (SEC Form 4)

    4 - Solo Brands, Inc. (0001870600) (Issuer)

    8/12/24 6:02:02 PM ET
    $DTC
    Recreational Games/Products/Toys
    Consumer Discretionary

    President & CEO Metz Christopher T bought $294,618 worth of shares (150,000 units at $1.96), increasing direct ownership by 150% to 250,000 units (SEC Form 4)

    4 - Solo Brands, Inc. (0001870600) (Issuer)

    6/13/24 6:55:56 PM ET
    $DTC
    Recreational Games/Products/Toys
    Consumer Discretionary

    Metz Christopher T bought $226,560 worth of shares (100,000 units at $2.27) (SEC Form 4)

    4 - Solo Brands, Inc. (0001870600) (Issuer)

    3/18/24 5:25:26 PM ET
    $DTC
    Recreational Games/Products/Toys
    Consumer Discretionary

    $AEMD
    $COST
    $DTC
    $FB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

    SAN DIEGO, March 24, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device for oncology and other indications, today announced that the independent Data Safety Monitoring Board (DSMB) overseeing its ongoing clinical trial AEMD-2022-06 has completed its scheduled safety review of the second cohort participant data and recommended advancing to the third and final cohort. They also stated that "no safety concerns were noted with Hemopurifier device/procedure". The trial, titled "Safety, Feasibility, and Dose-Finding Study of Aethlon Hemopurifier in Patients with Solid Tumors

    3/24/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

    NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are now available for on-demand viewing. The forum featured CEO chats and company presentations from leadership teams representing innovative companies across the biotechnology, medical device, and pharmaceutical sectors, offering investors insights into emerging technologies, strategic initiatives, and growth opportunities within the life sciences industry. REGISTER AND VIEW PRESENTATIONS HERE The presentations will be available 24/7 for 90 days. Investors,

    3/13/26 8:35:00 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

    SAN DIEGO, March 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it is evaluating a range of strategic opportunities and has engaged Maxim Group LLC ("Maxim") to act as the Company's exclusive financial advisor in connection with this process. The Company engaged Maxim following preliminary inbound interest regarding potential strategic opportunities. Maxim will assist the Company in reviewing a range of potential transactions, including partnerships, mergers, acquisitions or other opportunities involving the Co

    3/12/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $AEMD
    $COST
    $DTC
    $FB
    Leadership Updates

    Live Leadership Updates

    View All

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Pinterest Appoints Kecia Steelman to Board of Directors

    Pinterest, Inc. (NYSE:PINS) today announced that Kecia Steelman, President and Chief Executive Officer of Ulta Beauty, has been appointed to the company's Board of Directors, effective February 16, 2026. "Kecia is a seasoned executive with deep experience leading large-scale businesses and connecting consumers with brands they love," said Bill Ready, Chief Executive Officer of Pinterest. "Her track record of growing global businesses, building omnichannel experiences, and partnering closely with brands will be an asset as we continue to transform Pinterest into the leading visual discovery and AI-powered shopping platform, especially for Gen Z." Steelman joined Ulta Beauty in 2014 and h

    2/9/26 4:50:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AEMD
    $COST
    $DTC
    $FB
    Financials

    Live finance-specific insights

    View All

    Costco Wholesale Corporation Reports Second Quarter and Year-to-Date Operating Results for Fiscal 2026 and February Sales Results

    ISSAQUAH, Wash., March 05, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation ("Costco" or the "Company") (NASDAQ:COST) today announced its operating results for the second quarter (twelve weeks) and the first 24 weeks of fiscal 2026, ended February 15, 2026. Net sales for the quarter increased 9.1 percent, to $68.24 billion, from $62.53 billion last year. Net sales for the first 24 weeks increased 8.7 percent, to $134.22 billion, from $123.52 billion last year. Comparable sales for the second quarter and first 24 weeks of fiscal 2026 were as follows:   12 Weeks 12 Weeks 24 Weeks 24 Weeks     Adjusted*   Adjusted*  U.S.5.9% 6.4% 5.9% 6.1%  Canada10.1% 7.6% 8.3% 8.3%  Other Internation

    3/5/26 4:15:00 PM ET
    $COST
    Department/Specialty Retail Stores
    Consumer Discretionary

    Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

    Clinical and research programs continue to advance, supported by year-to-date cost efficiencies Conference Call Today at 4:30 p.m. ET SAN DIEGO, Feb. 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2025, and provided an update on recent developments.  Key Highlights Maintained Nasdaq Listing: Continued compliance with Nasdaq listing requirements, with all prior compliance matters remaining resolved. Clinical Progress: Cohort 2 of the Australian oncology tr

    2/12/26 4:15:00 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Pinterest Announces Fourth Quarter and Full Year 2025 Results, Delivers 14% Revenue Growth and Record Users

    Q4 Revenue of $1,319 million, an increase of 14% on a reported and 13% on a constant currency basis All-time high of 619 million global monthly active users, an increase of 12% Pinterest, Inc. (NYSE:PINS) today announced financial results for the quarter and year ended December 31, 2025. Revenue was $1,319 million for Q4 and $4,222 million for 2025, growing 14% and 16%, respectively, year over year. On a constant currency basis, revenue would have grown 13% and 15%, respectively, year over year. Global Monthly Active Users (MAUs) increased 12% year over year to 619 million. GAAP net income was $277 million for Q4 and $417 million for 2025. Adjusted EBITDA was $542 million and $

    2/12/26 4:06:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AEMD
    $COST
    $DTC
    $FB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Solo Brands Inc.

    SC 13G/A - Solo Brands, Inc. (0001870600) (Subject)

    11/8/24 11:01:10 AM ET
    $DTC
    Recreational Games/Products/Toys
    Consumer Discretionary

    SEC Form SC 13G/A filed by Solo Brands Inc. (Amendment)

    SC 13G/A - Solo Brands, Inc. (0001870600) (Subject)

    6/10/24 9:37:47 AM ET
    $DTC
    Recreational Games/Products/Toys
    Consumer Discretionary